Renaissance Technologies (RenTech)'s VCYT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 223,500 shares of Veracyte, Inc. (VCYT) worth $7.2 M, representing 0.01% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in VCYT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2018, adding 435,000 shares. Largest reduction occurred in Q3 2025, reducing 537,816 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Veracyte (VCYT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Veracyte (VCYT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +223,500 | New Buy | 223,500 | $32.21 |
| Q4 2025 | -72,584 | Sold Out | 0 | $0.00 |
| Q3 2025 | -537,816 | Reduce 88.11% | 72,584 | $34.33 |
| Q2 2025 | -221,600 | Reduce 26.63% | 610,400 | $27.03 |
| Q1 2025 | +231,300 | Add 38.51% | 832,000 | $29.65 |
| Q4 2024 | +6,400 | Add 1.08% | 600,700 | $39.60 |
| Q3 2024 | +173,500 | Add 41.23% | 594,300 | $34.04 |
| Q2 2024 | -69,100 | Reduce 14.10% | 420,800 | $21.67 |
| Q1 2024 | +410,000 | Add 513.14% | 489,900 | $22.16 |
| Q4 2023 | -110,900 | Reduce 58.12% | 79,900 | $27.51 |
| Q3 2023 | +103,501 | Add 118.56% | 190,800 | $22.33 |
| Q2 2023 | +87,299 | New Buy | 87,299 | $0.03 |
| Q3 2021 | -246,500 | Sold Out | 0 | $0.00 |
| Q2 2021 | +154,052 | Add 166.64% | 246,500 | $39.98 |
| Q1 2021 | +92,448 | New Buy | 92,448 | $53.75 |
| Q4 2019 | -203,500 | Sold Out | 0 | $0.00 |
| Q3 2019 | -322,000 | Reduce 61.27% | 203,500 | $24.00 |
| Q2 2019 | +70,700 | Add 15.55% | 525,500 | $28.51 |
| Q1 2019 | -126,160 | Reduce 21.72% | 454,800 | $25.02 |
| Q4 2018 | -359,440 | Reduce 38.22% | 580,960 | $12.58 |
| Q3 2018 | +435,000 | Add 86.07% | 940,400 | $9.55 |
| Q2 2018 | -7,400 | Reduce 1.44% | 505,400 | $9.34 |
| Q1 2018 | -36,500 | Reduce 6.64% | 512,800 | $5.56 |
| Q4 2017 | -5,459 | Reduce 0.98% | 549,300 | $6.53 |
| Q3 2017 | +193,359 | Add 53.50% | 554,759 | $8.77 |
| Q2 2017 | -41,200 | Reduce 10.23% | 361,400 | $8.33 |
| Q1 2017 | +185,700 | Add 85.62% | 402,600 | $9.18 |
| Q4 2016 | +45,126 | Add 26.27% | 216,900 | $7.74 |
| Q3 2016 | +104,974 | Add 157.15% | 171,774 | $7.61 |
| Q2 2016 | +29,426 | Add 78.73% | 66,800 | $5.03 |
| Q1 2016 | +19,655 | Add 110.93% | 37,374 | $5.40 |
| Q4 2015 | +17,719 | New Buy | 17,719 | $7.22 |
Renaissance Technologies (RenTech)'s Veracyte Investment FAQs
Renaissance Technologies (RenTech) first purchased Veracyte, Inc. (VCYT) in Q4 2015, acquiring 17,719 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Veracyte, Inc. (VCYT) for 32 quarters since Q4 2015.
Renaissance Technologies (RenTech)'s largest addition to Veracyte, Inc. (VCYT) was in Q3 2018, adding 940,400 shares worth $8.98 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 223,500 shares of Veracyte, Inc. (VCYT), valued at approximately $7.2 M.
As of the Q1 2026 filing, Veracyte, Inc. (VCYT) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Veracyte, Inc. (VCYT) was 940,400 shares, as reported at the end of Q3 2018.